Reproductive Health Matters
Volume 16, Issue 32 , Pages 86-96, November 2008

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications

  • Sue J Goldie

      Affiliations

    • Roger Irving Lee Professor of Public Health and Director, Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston MA, USA
    • ,
  • Meredith O'Shea

      Affiliations

    • Research Scientist and Program Manager, Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston MA, USA
    • ,
  • Mireia Diaz

      Affiliations

    • Research Scientist, Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, and Department of Paediatrics, Obstetrics, Gynaecology and Preventive Medicine, Programme in Public Health and the Methodology of Biomedical Research, Universitat Autónoma de Barcelona, Barcelona, Spain
    • ,
  • Sun-Young Kim

      Affiliations

    • Senior Research Fellow, Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston MA, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0968-8080(08)32409-4

doi:10.1016/S0968-8080(08)32409-4

Reproductive Health Matters
Volume 16, Issue 32 , Pages 86-96, November 2008

Article Tools